US Stock MarketDetailed Quotes

INBX Inhibrx Biosciences

Watchlist
  • 14.600
  • +0.720+5.19%
Close Dec 20 16:00 ET
  • 14.600
  • 0.0000.00%
Post 16:03 ET
211.35MMarket Cap0.12P/E (TTM)

Inhibrx Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Inhibrx Biosciences Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2024/Q3 -- / 0.000 --
-- 2024/Q2 -- / 0.000 --
-- 2024/Q1 0.000 / 0.000 --
-- 2023/Q4 1.634M / 50.000K --
-- 2023/Q3 119.000K / 0.000 --
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q41.634M / 50.000K--
--2023/Q3119.000K / 0.000--

Unlock Free Earnings Estimates

Inhibrx Biosciences Earnings Reports

  • Inhibrx Biosciences | 10-Q: Quarterly report

    Nov 15 06:20

  • Inhibrx Biosciences | 8-K: Inhibrx Biosciences Reports Third Quarter 2024 Financial Results

    Nov 15 05:32

  • Inhibrx Biosciences | 8-K: Inhibrx Biosciences Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

    Aug 14 04:13

  • Inhibrx Biosciences | 10-Q: Quarterly report

    Aug 14 04:11

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 18, 2024

    Hold

    • Buy

      0.00%

    • Hold

      100.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data